Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s42399-020-00373-2 http://scihub22266oqcxt.onion/10.1007/s42399-020-00373-2 C7320840!7320840!32838151     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       SN+Compr+Clin+Med 2020 ; 2 (8): 1083-8 Nephropedia Template TP {{tp|p=32838151|t=2020. Novel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar |pdf=|usr=}}{{32838151}} gab.com Text Novel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar JO: SN Compr Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=32838151 #FOAvip Currently, pandemic coronavirus disease 2019 (COVID-19) is the biggest threat to all human beings globally. Till June 8, 2020, it has infected 6,931,000 people and caused 400,857 deaths worldwide. The first case was identified in a patient with influenza-like symptoms along with severe acute respiratory syndrome in Wuhan, China, in December 2019 and now it has spread in more than 200 countries. Since there is no approved cure for this disease until now, there is a lot of mass fear, apprehensions, and questions globally regarding (i) genetic origin and history of the novel coronavirus, (ii) what are the first-line therapies for those who contract this disease, and (iii) what could be the potential vaccine targets. In this short review, we have tried to address these queries in the simplest manner and compiled the history of previous coronaviruses, recent developments in the COVID-19 research, potential future therapeutics, and possible targets to cure the disease. Twit Text FOAVip Novel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar ????SN Compr Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=32838151 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32838151 #FOAvip English Wikipedia <ref>{{Cite pmid|32838151}}</ref> Novel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar #MMPMID32838151 Singh AB; Singh N SN Compr Clin Med 2020[]; 2 (8): 1083-8 PMID32838151show ga Currently, pandemic coronavirus disease 2019 (COVID-19) is the biggest threat to all human beings globally. Till June 8, 2020, it has infected 6,931,000 people and caused 400,857 deaths worldwide. The first case was identified in a patient with influenza-like symptoms along with severe acute respiratory syndrome in Wuhan, China, in December 2019 and now it has spread in more than 200 countries. Since there is no approved cure for this disease until now, there is a lot of mass fear, apprehensions, and questions globally regarding (i) genetic origin and history of the novel coronavirus, (ii) what are the first-line therapies for those who contract this disease, and (iii) what could be the potential vaccine targets. In this short review, we have tried to address these queries in the simplest manner and compiled the history of previous coronaviruses, recent developments in the COVID-19 research, potential future therapeutics, and possible targets to cure the disease. äNovel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar (epmc).pdf DeepDyve Pubget Overpricing